A citation-based method for searching scientific literature

Martin Kolb, Benjamin Bondue, Alberto Pesci, Yasunari Miyazaki, Jin Woo Song, Nitin Y Bhatt, John T Huggins, Justin M Oldham, Maria L Padilla, Jesse Roman, Shane Shapera. Eur Respir Rev 2018
Times Cited: 57







List of co-cited articles
383 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
Harold R Collard, Christopher J Ryerson, Tamera J Corte, Gisli Jenkins, Yasuhiro Kondoh, David J Lederer, Joyce S Lee, Toby M Maher, Athol U Wells, Katerina M Antoniou,[...]. Am J Respir Crit Care Med 2016
539
59

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
43

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
43

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
36

Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome.
J W Song, S-B Hong, C-M Lim, Y Koh, D S Kim. Eur Respir J 2011
428
33

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Kevin R Flaherty, Athol U Wells, Vincent Cottin, Anand Devaraj, Simon L F Walsh, Yoshikazu Inoue, Luca Richeldi, Martin Kolb, Kay Tetzlaff, Susanne Stowasser,[...]. N Engl J Med 2019
430
28

Acute exacerbations of fibrotic interstitial lung diseases.
Atsushi Suzuki, Yasuhiro Kondoh, Kevin K Brown, Takeshi Johkoh, Kensuke Kataoka, Junya Fukuoka, Tomoki Kimura, Toshiaki Matsuda, Toshiki Yokoyama, Jun Fukihara,[...]. Respirology 2020
32
50

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
26

Acute exacerbations of idiopathic pulmonary fibrosis.
Harold R Collard, Bethany B Moore, Kevin R Flaherty, Kevin K Brown, Robert J Kaner, Talmadge E King, Joseph A Lasky, James E Loyd, Imre Noth, Mitchell A Olman,[...]. Am J Respir Crit Care Med 2007
731
24

Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis.
I-Nae Park, Dong Soon Kim, Tae Sun Shim, Chae-Man Lim, Sang Do Lee, Younsuck Koh, Woo Sung Kim, Won Dong Kim, Se Jin Jang, Thomas V Colby. Chest 2007
211
22

Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features.
D S Kim, J H Park, B K Park, J S Lee, A G Nicholson, T Colby. Eur Respir J 2006
307
21

Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases.
Takafumi Suda, Yusuke Kaida, Yutaro Nakamura, Noriyuki Enomoto, Tomoyuki Fujisawa, Shiro Imokawa, Hideo Hashizume, Tateaki Naito, Dai Hashimoto, Yasuo Takehara,[...]. Respir Med 2009
136
19

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
15

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases.
Vincent Cottin, Nikhil A Hirani, David L Hotchkin, Anoop M Nambiar, Takashi Ogura, María Otaola, Dirk Skowasch, Jong Sun Park, Hataya K Poonyagariyagorn, Wim Wuyts,[...]. Eur Respir Rev 2018
131
15

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Oliver Distler, Kristin B Highland, Martina Gahlemann, Arata Azuma, Aryeh Fischer, Maureen D Mayes, Ganesh Raghu, Wiebke Sauter, Mannaig Girard, Margarida Alves,[...]. N Engl J Med 2019
404
15

Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
Toru Arai, Tomoko Kagawa, Yumiko Sasaki, Reiko Sugawara, Chikatoshi Sugimoto, Kazunobu Tachibana, Masanori Kitaichi, Masanori Akira, Seiji Hayashi, Yoshikazu Inoue. Respirology 2016
23
39

Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
Ryo Tachikawa, Keisuke Tomii, Hiroyuki Ueda, Kazuma Nagata, Shigeki Nanjo, Ayako Sakurai, Kyoko Otsuka, Reiko Kaji, Michio Hayashi, Nobuyuki Katakami,[...]. Respiration 2012
77
15

Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.
David A Lynch, Nicola Sverzellati, William D Travis, Kevin K Brown, Thomas V Colby, Jeffrey R Galvin, Jonathan G Goldin, David M Hansell, Yoshikazu Inoue, Takeshi Johkoh,[...]. Lancet Respir Med 2018
383
15

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
985
14

Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis.
Teng Moua, Blair D Westerly, Megan M Dulohery, Craig E Daniels, Jay H Ryu, Kaiser G Lim. Chest 2016
48
16

Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.
Philip L Molyneaux, Michael J Cox, Athol U Wells, Ho Cheol Kim, Wonjun Ji, William O C Cookson, Miriam F Moffatt, Dong Soon Kim, Toby M Maher. Respir Res 2017
89
14

Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials.
Harold R Collard, Eric Yow, Luca Richeldi, Kevin J Anstrom, Craig Glazer. Respir Res 2013
119
14

A multidimensional index and staging system for idiopathic pulmonary fibrosis.
Brett Ley, Christopher J Ryerson, Eric Vittinghoff, Jay H Ryu, Sara Tomassetti, Joyce S Lee, Venerino Poletti, Matteo Buccioli, Brett M Elicker, Kirk D Jones,[...]. Ann Intern Med 2012
598
14

Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis.
Yasunari Miyazaki, Tomoya Tateishi, Takumi Akashi, Yoshio Ohtani, Naohiko Inase, Yasuyuki Yoshizawa. Chest 2008
93
14


Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
882
12

Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences.
Motoki Natsuizaka, Hirofumi Chiba, Koji Kuronuma, Mitsuo Otsuka, Kazumi Kudo, Mitsuru Mori, Masashi Bando, Yukihiko Sugiyama, Hiroki Takahashi. Am J Respir Crit Care Med 2014
224
12

Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors.
Virginie Simon-Blancal, Olivia Freynet, Hilario Nunes, Diane Bouvry, Nicolas Naggara, Pierre-Yves Brillet, Damien Denis, Yves Cohen, François Vincent, Dominique Valeyre,[...]. Respiration 2012
87
12

Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
Noriyuki Enomoto, Yoshiyuki Oyama, Yasunori Enomoto, Hideki Yasui, Masato Karayama, Masato Kono, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa,[...]. Chron Respir Dis 2019
17
41

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
Toby M Maher, Tamera J Corte, Aryeh Fischer, Michael Kreuter, David J Lederer, Maria Molina-Molina, Judit Axmann, Klaus-Uwe Kirchgaessler, Katerina Samara, Frank Gilberg,[...]. Lancet Respir Med 2020
161
12

Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Athol U Wells, Kevin R Flaherty, Kevin K Brown, Yoshikazu Inoue, Anand Devaraj, Luca Richeldi, Teng Moua, Bruno Crestani, Wim A Wuyts, Susanne Stowasser,[...]. Lancet Respir Med 2020
107
12

The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype.
Amy L Olson, Alex H Gifford, Naohiko Inase, Evans R Fernández Pérez, Takafumi Suda. Eur Respir Rev 2018
55
10

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
Lutz Wollin, Eva Wex, Alexander Pautsch, Gisela Schnapp, Katrin E Hostettler, Susanne Stowasser, Martin Kolb. Eur Respir J 2015
348
10

Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease.
Kevin R Flaherty, Kevin K Brown, Athol U Wells, Emmanuelle Clerisme-Beaty, Harold R Collard, Vincent Cottin, Anand Devaraj, Yoshikazu Inoue, Florence Le Maulf, Luca Richeldi,[...]. BMJ Open Respir Res 2017
94
10

Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.
MeiLan K Han, Yueren Zhou, Susan Murray, Nabihah Tayob, Imre Noth, Vibha N Lama, Bethany B Moore, Eric S White, Kevin R Flaherty, Gary B Huffnagle,[...]. Lancet Respir Med 2014
213
10

Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Mengshu Cao, Jian Sheng, Xiaohua Qiu, Dandan Wang, Dongmei Wang, Yang Wang, Yonglong Xiao, Hourong Cai. BMC Pulm Med 2019
12
50

Hypersensitivity Pneumonitis: Perspectives in Diagnosis and Management.
Martina Vasakova, Ferran Morell, Simon Walsh, Kevin Leslie, Ganesh Raghu. Am J Respir Crit Care Med 2017
189
10

Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory.
Margaret L Salisbury, Tian Gu, Susan Murray, Barry H Gross, Aamer Chughtai, Mohamed Sayyouh, Ella A Kazerooni, Jeffrey L Myers, Amir Lagstein, Kristine E Konopka,[...]. Chest 2019
72
10

Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series.
Amy L Olson, Tristan J Huie, Steve D Groshong, Gregory P Cosgrove, William J Janssen, Marvin I Schwarz, Kevin K Brown, Stephen K Frankel. Chest 2008
59
10

Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Christopher J Ryerson, Jeffrey L Myers, Michael Kreuter, Martina Vasakova, Elena Bargagli, Jonathan H Chung, Bridget F Collins, Elisabeth Bendstrup,[...]. Am J Respir Crit Care Med 2020
130
10

Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF.
Erica Farrand, Eric Vittinghoff, Brett Ley, Atul J Butte, Harold R Collard. Respirology 2020
24
25

Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence.
Luca Richeldi, Francesco Varone, Miguel Bergna, Joao de Andrade, Jeremy Falk, Robert Hallowell, Stéphane Jouneau, Yasuhiro Kondoh, Lee Morrow, Winfried Randerath,[...]. Eur Respir Rev 2018
39
12

What's in a name? That which we call IPF, by any other name would act the same.
Athol U Wells, Kevin K Brown, Kevin R Flaherty, Martin Kolb, Victor J Thannickal. Eur Respir J 2018
121
8

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
8

Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trials.
Luca Richeldi, Vincent Cottin, Roland M du Bois, Moisés Selman, Toshio Kimura, Zelie Bailes, Rozsa Schlenker-Herceg, Susanne Stowasser, Kevin K Brown. Respir Med 2016
210
8

Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases.
Jeffrey J Swigris, Kevin K Brown, Rayid Abdulqawi, Ketan Buch, Daniel F Dilling, Dirk Koschel, Krishna Thavarajah, Rade Tomic, Yoshikazu Inoue. Eur Respir Rev 2018
24
20

Role of imaging in progressive-fibrosing interstitial lung diseases.
Simon L F Walsh, Anand Devaraj, Juan Ignacio Enghelmayer, Kazuma Kishi, Rafael S Silva, Nina Patel, Milton D Rossman, Claudia Valenzuela, Carlo Vancheri. Eur Respir Rev 2018
23
21

The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
Brett Ley, Chad A Newton, Isabel Arnould, Brett M Elicker, Travis S Henry, Eric Vittinghoff, Jeffrey A Golden, Kirk D Jones, Kiran Batra, Jose Torrealba,[...]. Lancet Respir Med 2017
112
8

The natural history of progressive fibrosing interstitial lung diseases.
Martin Kolb, Martina Vašáková. Respir Res 2019
66
8

Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.
B Bradley, H M Branley, J J Egan, M S Greaves, D M Hansell, N K Harrison, N Hirani, R Hubbard, F Lake, A B Millar,[...]. Thorax 2008
471
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.